Skip to content
  • 2026 Conference
  • CAREGIVER SUPPORT
  • QUICK RESOURCES
  • PODCAST
  • CONNECT: Family Support
    • New Diagnosis
    • Support Programs
      • Family Support
      • First 100 Days
      • Caregiver Support Groups
    • 2026 Conference
    • Family Stories
    • Resource Library
  • CARE: About PMS
    • What is Phelan-McDermid Syndrome?
    • How Phelan-McDermid Syndrome is Diagnosed
    • Medical Issues & Clinical Care
    • PMS Neuropsychiatric Consultation Group – ECHO
    • Genetic Counselors
    • PMS By The Numbers
  • CURE: Research
    • Strategic Priorities
    • Funded Research
      • Research Grants Program
    • Family Participation Opportunities
      • Participation in Research
      • Clinical Trials in Phelan-McDermid Syndrome
    • Drugs In Development
    • For Research Partners
    • PMS DataHub
  • Foundation
    • About Us
    • Our History
    • Leadership
    • Our Financials
  • Get Involved
    • Fundraise
    • Phelan Lucky
    • Advocate
    • Events
    • Volunteer
  • News & Updates
  • Contact Us
  • CONNECT: Family Support
    • New Diagnosis
    • Support Programs
      • Family Support
      • First 100 Days
      • Caregiver Support Groups
    • 2026 Conference
    • Family Stories
    • Resource Library
  • CARE: About PMS
    • What is Phelan-McDermid Syndrome?
    • How Phelan-McDermid Syndrome is Diagnosed
    • Medical Issues & Clinical Care
    • PMS Neuropsychiatric Consultation Group – ECHO
    • Genetic Counselors
    • PMS By The Numbers
  • CURE: Research
    • Strategic Priorities
    • Funded Research
      • Research Grants Program
    • Family Participation Opportunities
      • Participation in Research
      • Clinical Trials in Phelan-McDermid Syndrome
    • Drugs In Development
    • For Research Partners
    • PMS DataHub
  • Foundation
    • About Us
    • Our History
    • Leadership
    • Our Financials
  • Get Involved
    • Fundraise
    • Phelan Lucky
    • Advocate
    • Events
    • Volunteer
  • News & Updates
  • Contact Us
Join
Donate
  • 2026 Conference
  • CONNECT: Family Support
    • New Diagnosis
    • Programs
      • Family Support
      • “First 100 Days”
      • Caregiver Support Groups
    • Family Stories
    • Resource Library
  • CARE: About PMS
    • What is Phelan-McDermid syndrome?
    • How PMS is Diagnosed
    • Medical Issues & Clinical Care
    • PMS Neuropsychiatric Consultation Group – ECHO
    • About Genetic Counseling
    • PMS By The Numbers
  • CURE: Research
    • Strategic Priorities
    • Funded Research
      • Research Grants Program
    • Family Participation Opportunities 
      • Participation in Research
      • Clinical Trials
    • Drugs In Development
    • For Research Partners
    • PMS Datahub
  • Foundation
    • About Us
    • Our History
    • Leadership
    • Our Financials
    • PMSF News
    • Contact Us
  • Get Involved
    • Fundraise
      • Phelan Lucky
    • Advocate
    • Events
    • Volunteer
  • Join
  • Donate
Breaking Down NIH Funding for Research

Breaking Down NIH Funding for Research

With a past annual budget of nearly $50 billion (yes, that’s with a B!), the National Institute of Health (NIH) is…

Continue ReadingBreaking Down NIH Funding for Research
PYC Therapeutics Webinar Takeaways

PYC Therapeutics Webinar Takeaways

We are so grateful to PYC Therapeutics for their informative webinar on PYC-002, an RNA-based gene therapy, held on March 13,…

Continue ReadingPYC Therapeutics Webinar Takeaways
2023 PMSF Grant Awardees – Round-Up

2023 PMSF Grant Awardees – Round-Up

Over the past month, I’ve had the opportunity to interview each of our 2023 PMSF Grant Awardees for our podcast, The…

Continue Reading2023 PMSF Grant Awardees – Round-Up
Epilepsy and Seizure Update from the Natural History Study

Epilepsy and Seizure Update from the Natural History Study

Seizures are a big concern for families with children with Phelan-McDermid syndrome, but it's not always clear when or why they…

Continue ReadingEpilepsy and Seizure Update from the Natural History Study
Updates to Pharmacological Recommendations for the Management of Phelan-McDermid syndrome

Updates to Pharmacological Recommendations for the Management of Phelan-McDermid syndrome

We are excited to release updates to our Pharmacologic Recommendations, which were recently finalized by our Phelan-McDermid Syndrome Neuropsychiatric Consultation Group…

Continue ReadingUpdates to Pharmacological Recommendations for the Management of Phelan-McDermid syndrome
Exciting News: The Phelan-McDermid Syndrome DataHub is Now Available in Spanish!

Exciting News: The Phelan-McDermid Syndrome DataHub is Now Available in Spanish!

At the Phelan-McDermid Syndrome Foundation, we are committed to making resources accessible to all families in our community. That’s why we’re…

Continue ReadingExciting News: The Phelan-McDermid Syndrome DataHub is Now Available in Spanish!
An Important Announcement from Our CEO, Ronni Blumenthal

An Important Announcement from Our CEO, Ronni Blumenthal

A Message from Our CEO: Preparing for a New ChapterIt is with both gratitude and a sense of celebration that we…

Continue ReadingAn Important Announcement from Our CEO, Ronni Blumenthal

Contact Us

8 Sorrento Drive, Osprey, FL 34229

phone: 941-485-8000

fax: 941-220-6605

email: info@pmsf.org

Tax ID: 04-3673104

Engage With Us

  • News & Blog Posts
  • Resource Library
  • Events
  • Website Feedback
  • Join Our Membership

Connect With Us

Facebook-f Twitter Youtube Instagram

Translate

Financial Conflict of Interest

Privacy Policy

Charity Disclosures
Copyright © 2024 Phelan-McDermid Syndrome Foundation. All rights reserved. Any information provided to members or the general public is provided for educational purposes only, and is not intended to replace professional advice from doctors or therapists.

Log in

Become a part of our community!
Forgot your password? Get help

Reset password

Recover your password
A password reset link will be e-mailed to you.
Back to
Login
×
Close Panel

By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Accept